AZT 5'-Phosphonates: Achievements and Trends in the Treatment and Prevention of HIV Infection

about

AZT 5'-Phosphonates: Achievements and Trends in the Treatment and Prevention of HIV Infection

Item

http://www.wikidata.org/entity/Q37358511

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

AZT 5'-Phosphonates: Achieveme ...... nd Prevention of HIV Infection

@en

AZT 5'-Phosphonates: Achieveme ...... d Prevention of HIV Infection.

@nl

type

Item

label

AZT 5'-Phosphonates: Achieveme ...... nd Prevention of HIV Infection

@en

AZT 5'-Phosphonates: Achieveme ...... d Prevention of HIV Infection.

@nl

prefLabel

AZT 5'-Phosphonates: Achieveme ...... nd Prevention of HIV Infection

@en

AZT 5'-Phosphonates: Achieveme ...... d Prevention of HIV Infection.

@nl

P1476

AZT 5'-Phosphonates: Achieveme ...... nd Prevention of HIV Infection

@en

P2093

Capital A Cyrillic L Khandazhinskaya

http://www.w3.org/2001/XMLSchema#string

E A Shirokova

http://www.w3.org/2001/XMLSchema#string

P2860

3'-Azido-3'-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes

Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine

Nature, time course and dose dependence of zidovudine-related side effects: results from the Multicenter Canadian Azidothymidine Trial

Antiviral activity and resistance profile of phosphazid--a novel prodrug of AZT

Multidose pharmacokinetics of ritonavir and zidovudine in human immunodeficiency virus-infected patients

Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells.

Strategies in the design of prodrugs of anti-HIV agents.

Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist.

Prodrugs and soft drugs.

Current HIV therapeutics: mechanistic and chemical determinants of toxicity.

P304

54-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24307936

http://www.w3.org/2001/XMLSchema#string

P921

prevention of HIV/AIDS

P932

3848067

http://www.w3.org/2001/XMLSchema#string